There are a lot of analyses already about what has gone wrong with the European vaccine effort. It seems to be partly a mixture of being a bit stingy with proc

There are a lot of analyses already about what has gone wrong with the European vaccine effort. It seems to be partly a mixture of being a bit stingy with procurement, being skeptical of new RNA vaccines, putting too much stock in sanofi and j&j, and requiring everything ratified by every country to proceed. In fact it was going so slowly that four countries decided to organise their own precurement, and that became the EU effort. So it seems mostly a problem of procurement/supply. A smaller country like Israel has a simpler logistical issue.